Welcome to PRI

Founded in 2002, the Pharmaceutical Research Institute (PRI) at Albany College of Pharmacy and Health Sciences is a center for drug discovery and development.

EXPERTISE   PRI investigators are experts in nanotechnology, medicinal chemistry, molecular biology, and cell biology.

AREAS of FOCUS   Hematology/oncology, cardiovascular (dyslipidemia), ophthalmology, vascular diseases, neurology, inflammation.

TEACHING and LEARNING   Pharmacy students, graduate students, and visiting scholars from around the world visit PRI to conduct research and learn the latest advances across a wide range of therapeutic areas.

The 8th Annual Research Forum Agenda was held on Jan. 27, 2018 at ACPHS, featuring Keynote Speakers and talks and posters in a variety of disciplines.

View the Annual Research Forum Agenda 2018

PRI Executive Director Wins the Kuwait Prize

Congratulations Dr. Mousa !

Dr. Shaker Mousa has been named a 2017 recipient of the Kuwait Prize, one of the world’s most prestigious awards for achievements in science.

* * * Watch a video highlighting Dr. Mousa’s career accomplishments* * *

Sponsored by the Kuwait Foundation for the Advancement of Sciences (KFAS), this annual award recognizes lifetime contributions of Arab scientists across the globe. Dr. Mousa was honored in the category of Applied Sciences (Applied Medical & Applied Allied Health Sciences). The Kuwait Prize was first awarded in 1979. Award recipients are selected based on evaluations from local and international scientific institutions.

It is my great honor to receive the Kuwait Prize for Applied Sciences, and I wish to thank the KFAS for using this awards program to stimulate interest in the scientific community and help inspire further advances,” said Dr. Mousa. “I truly believe that science knows no boundaries. The only chance we have to find better therapies for complex diseases is for the global scientific community to work together, and I value being part of that process.”

PRI Celebrates 15 Years !!

Left to Right: W. Li, K. Godugu, S.A. Mousa, P. Phillips. M. Jayaraman, D. Bharali, S. Thangirala,

M. Rajabi, B. Hay, K. Keating, O. Karakus


SEPTEMBER 25, 2017 – View the full brochure and schedule 


Left to right, Dr. Weikun Li (PRI), Dr. Mousa, Dr. Kavitha Godugu (PRI)

Dr. Li’s poster was titled, “Formulation and pharmacokinetics of diamino propane tetraiodothyroacetic acid-conjugated biodegradable polymeric nanoparticles and anti-angiogenesis efficacy” with coauthors Murat Yalcin, Dhruba J. Bharali, Quishan Lin, Kavitha Godugu, and Shaker A. Mousa.

Dr. Godugu’s poster was titled, “Anticancer Efficacy of P-bi-TAT, A Novel Thyrointegrin Receptor Antagonist in Solid Tumors” with coauthors Sudha Thangirala, Mehdi Rajab, and Shaker A. Mousa.

Recent Publications

  • Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac

    T Sudha, DJ Bharali, M Yalcin, NHE Darwish, M Debreli Coskun, KA Keating, H-Y Lin, PJ Davis, SA Mousa (2017)
    Nanomedicine 12(3):195-205.

    Read more
  • Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery

    W Li, M Yalcin, Q Lin, MM Ardawi, SA Mousa (2017)
    Journal of Controlled Release 248:117-124

    Read more